High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease

J Inherit Metab Dis. 2005;28(5):715-22. doi: 10.1007/s10545-005-0003-3.

Abstract

Anderson-Fabry disease is a rare lysosomal storage disorder. It results from a deficiency of the lysosomal alpha-galactosidase A and leads to progressive accumulation of globotriaosylceramide in the endothelium and tissue cells of various organs. Some of the typical clinical findings such as tiredness, dry skin, myalgia and arthralgia as well as vague gastrointestinal complaints are also symptoms of hypothyroidism. Therefore, we studied the thyroid function in patients with Anderson-Fabry disease. Thyroid function was studied in 11 patients (6 female, 5 male) with Anderson-Fabry disease by measuring thyroid-stimulating hormone (TSH) and free thyroxine serum levels. Nine patients had chronic kidney disease with stage 1 and two with stage 5. Subclinical hypothyroidism (normal serum free thyroxine concentrations along with elevated serum TSH levels) was found in 4 of 11 patients (36.4%). Subclinical hypothyroidism was observed in both male and female patients as well as in patients with stage 1 and stage 5 kidney disease. Subclinical hypothyroidism is a common finding in patients with Anderson-Fabry disease, showing an excess prevalence as compared to the normal population. The high frequency seems to be relevant regarding the potential consequences of a hypothyroid state.

MeSH terms

  • Adult
  • Fabry Disease / complications*
  • Fabry Disease / diagnosis*
  • Fabry Disease / epidemiology
  • Female
  • Humans
  • Hypothyroidism / blood
  • Hypothyroidism / complications
  • Hypothyroidism / diagnosis*
  • Hypothyroidism / epidemiology
  • Kidney Diseases / complications
  • Lysosomal Storage Diseases / complications
  • Lysosomal Storage Diseases / diagnosis
  • Lysosomal Storage Diseases / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • Thyroid Function Tests
  • Thyroid Gland / pathology
  • Thyrotropin / blood
  • Thyroxine / blood

Substances

  • Thyrotropin
  • Thyroxine